Amalgamated Bank Vera Therapeutics, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,535 shares of VERA stock, worth $44,177. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,535
Previous 1,535
-0.0%
Holding current value
$44,177
Previous $36,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VERA
# of Institutions
197Shares Held
65.7MCall Options Held
1.58MPut Options Held
358K-
Avoro Capital Advisors LLC New York, NY6.3MShares$181 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$129 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$98.6 Million9.64% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.35MShares$96.4 Million1.81% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$96.1 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $778M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...